Shopping Cart
Remove All
Your shopping cart is currently empty
Diprotin A (TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $49 | 5 days | 5 days |
| Description | Diprotin A (TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV). |
| In vitro | Diprotin A can increase the phosphorylation of Src and vascular endothelial cadherin (VE-cadherin) in human endothelial cells and destroy the connection between endothelial cells, which can be blocked by CXCR4 (SDF-1α receptor) or Src inhibitor Weaken. |
| In vivo | Diprotin A collectively induces vascular leakage by increasing the SDF-1α/CXCR4/Src/VE-cadherin signaling pathway. In the model of retinopathy of prematurity, Diprotin A will not only increase retinal blood vessels, but also increase leakage. In addition, in the murine model of diabetic retinopathy, bupstatin A increases the phosphorylation of Src and VE-cadherin and aggravates retinal vascular leakage. |
| Synonyms | Ile-Pro-Pro (TFA) |
| Molecular Weight | 455.47 |
| Formula | C19H32F3N3O6 |
| Cas No. | 209248-71-5 |
| Relative Density. | no data available |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 77.5 mg/mL (170.15 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.